Company research / PKTX

ProtoKinetix, Inc. (PKTX)

Build a valuation ↗↓ Download CSV

CIK 0001128189 · OTC · Pharmaceutical Preparations

Sector Manufacturing
Incorporated NV
Fiscal year ends Dec 31

For the year ended 2014-12-31, ProtoKinetix, Inc. reported revenue of $0.

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: 10-K · 2026-09-03

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.

Period ended	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31
Net Income	-$393.6K	-$364.2K	-$415.5K	-$1.91M	-$2.33M	-$7.64M	-$4.20M	-$1.22M	-$1.51M	-$1.52M
EPS (Diluted)	$0.00	$0.00	$-0.01	$-0.01	—	—	—	—	—	—
Total Assets	$483.4K	$466.1K	$480.6K	$462.9K	$446.2K	$469.2K	$585.9K	$324.9K	$518.1K	$542.1K
Total Liabilities	—	—	—	—	—	$45.0K	$25.5K	$78.9K	$144.6K	$45.3K
Shareholders' Equity	$297.9K	$342.1K	$435.9K	$421.3K	$353.0K	$424.2K	$560.4K	$246.0K	$373.6K	$496.8K
Cash & Equivalents	—	—	—	—	$57.6K	$193.4K	$377.4K	—	—	—
Operating Cash Flow	-$135.4K	-$223.1K	-$376.0K	-$804.7K	-$889.9K	-$881.3K	-$850.7K	-$453.5K	-$605.1K	-$820.3K
Shares Outstanding	406.83M	371.88M	346.21M	322.88M	297.39M	285.96M	275.40M	259.79M	251.35M	237.95M
Weighted Average Diluted Shares	386.28M	358.56M	333.10M	307.39M	291.87M	278.60M	268.98M	256.22M	246.60M	221.61M
EPS (Basic)	$0.00	$0.00	$-0.01	$-0.01	—	—	—	—	—	—